WCM
NVO

Weld Capital Management’s Novo Nordisk NVO Stock Holding History

Weld Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,140
Closed -$422K – 881
2019
Q1 		$422K Sell
16,140
-54,810
-77% -$1.35M 0.08% 438
2018
Q4 		$1.63M Buy
+70,950
New +$1.58M 0.37% 44

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Weld Capital Management's NVO Position: Q2 2019 in Review

Weld Capital Management sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 16,140 shares — an estimated $422K sold.

Weld Capital Management first reported a position in NVO in Q4 2018 and held it in 2 quarters. The position peaked at $1.63M in Q4 2018. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Weld Capital Management reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
  • Weld Capital Management sold 16,140 Novo Nordisk shares in Q2 2019, an estimated $422K.
  • Weld Capital Management first reported a position in Novo Nordisk in Q4 2018 and held it in 2 quarters.
  • Weld Capital Management's Novo Nordisk position peaked at $1.63M in Q4 2018.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.